CSMS 49292372PGAACE OPSinformational

Food and Drug Administration (FDA) incorrectly rejecting valid FSV email addresses

Published Sep 7, 2021

Summary

CBP announced that an FDA deployment caused valid FSV email addresses to be incorrectly rejected on some entry lines, and the validation logic has been reverted to prevent further errors; affected filers should retransmit rejected entries and await a future CSMS with the new deployment date.

Summary is machine-generated at the linking layer for discovery only. Refer to the source bulletin for authoritative guidance.

CSMS 49292372 · full bulletin